Find your next paid study

Chestnut Health SystemsNCT07873944

~$50 – $1,500

Actual pay is set by the research site.

AsthmaCOPDCystic Fibrosis+4 more

Advancing Telemedicine in Pulmonology: Acoustic-waveform Respiratory Evaluation (AWARE) Via Sensing and Machine Learning on Smartphones

The study will evaluate the feasibility of using smartphone speakers and microphones to evaluate the caliber of the airways, detect airway obstruction, aid in …

Indiana UniversityNCT06512064

Actual pay is set by the research site.

Effects of Social Feedback on Intracranial EEG

This study aims to assess the impact of social influence on direct neural recordings in human patients undergoing surgical treatment of epilepsy. 24 patients r…

Social InfluenceEpilepsy

Trustees of Dartmouth CollegeNCT06975800

Actual pay is set by the research site.

Obesity (BMI>30)Insulin Resistance

Interplay of Central and Peripheral Vascular Effects of Insulin in Obesity

Determine the impact of obesity with insulin resistance on the neurovascular response to brain insulin stimulation.

University of Missouri-ColumbiaNCT07653464

~$500 – $7,500

Actual pay is set by the research site.

HIV/STI IncidenceCommunication About Health Information

Parents ASSIST for All LGBTQ Youth (Hillman)

The study is centered on helping parents answer and meet the sexuality-specific questions and needs of transgender, gender diverse, lesbian or bisexual female …

University of PennsylvaniaNCT07825571

Actual pay is set by the research site.

Investigation of Impact of Milk Consumption on H5 Influenza Detection in Respiratory Specimens

The purpose of this study is to determine whether drinking pasteurized milk (milk heated to kill harmful germs) that contains inactive particles of a flu virus…

Influenza

Emory UniversityNCT06850298

Actual pay is set by the research site.

Pilot Study on the Effects of Psilocybin on Belief Updating and Insight Formation

The primary aim of this phase I mechanistic pilot study is to evaluate the effects of psilocybin on aspects of cognition in healthy adult volunteers. Up to 24 …

Phase I

Brown UniversityNCT07818564

~$500 – $7,500

Actual pay is set by the research site.

Probing Brain Network Mechanisms Underlying Late-Life Prolonged Grief Disorder

After losing a loved one, most successfully navigate acute grief and adapt to the loss within about 1 year, but in about 10%, prolonged grief disorder (PGD) en…

Prolonged Grief Disorder

Medical College of WisconsinNCT07738133

Actual pay is set by the research site.

Healthy Female Participants

A Phase 1 Study to Evaluate the Mass Balance, Metabolism, Excretion, and Pharmacokinetics of [14C]Navlimetostat (BMS-986504) at Steady State in Healthy Female Participants

The purpose of this study is to evaluate the metabolism, the routes and extent of elimination, and drug levels of \[14C\]Navlimetostat (BMS-986504) in healthy …

Bristol-Myers SquibbNCT07777133

~$500 – $11,250

Actual pay is set by the research site.

Leukemia, Myeloid, AcuteLeukemia, Lymphocytic, AcuteMultiple Myeloma+1 more

A Phase 1/2, Open-Label, Dose-Escalation, Dose-Expansion Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia and Other Selected Hematologic Malignancies, With and Without Mixed Lineage Leukemia (MLL) Rearrangement or Nucleophosmin 1 (NPM1) Mutation (Horizen-1)

A phase 1/2 dose escalation / dose expansion study of Enzomenib (DSP-5336) in patients with acute leukemia.

Sumitomo Pharma America, Inc.NCT04988555

~$150 – $4,200

Actual pay is set by the research site.

EXERT-BC Cardio: Randomized Study of EXErcise Regimens After Treatment for Breast Cancer Utilizing Cardio or Conditioning Training

In this study, the investigators hypothesize that observed intense resistance training with conditioning elicits similar changes in body composition, muscle ma…

CancerBreast Cancer

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)NCT07739563

~$10 – $1,125

Actual pay is set by the research site.

PIK3CA MutationSolid Tumor, AdultHER2-negative Breast Cancer+4 more

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

This is an open-label, FIH study designed to evaluate the maximum tolerated dose, recommended Phase 2 dose, safety, tolerability, PK, pharmacodynamics, and pre…